Analysts recommend buying Biogen (BIIB) shares as breakout signals bullish trend
Investors should consider Biogen (BIIB) as a promising opportunity in the biotech sector, given its recent technical breakout and potential for significant upside, while also keeping an eye on the broader Bio-Tech ETF (XBI) for safer exposure.